CP and metabolic dysfunction-associated steatotic liver disease: Interestingly, by adding F-CP, 2h-CP, ABG, FBG, 2hBG, HOMA-IR, and HbA1c on the basis of model 1, FT3 showed significant associations with the prevalence of NAFLD (model 2, OR = 1.286, 95% CI 1.006-1.644, P < 0.05), and it was still statistically significant after further adjustment for urea, CR, UA, and eGFR (model 3, OR = 1.367, 95% CI 1.068-1.751, P < 0.05).